South Africa: We Need to Do for TB Vaccines What We've Done for Covid-19
[spotlight] It is little wonder that some TB vaccine researchers suffer from a rare syndrome that understandably threatens their mental health. Symptoms include frustration, impatience, irritability, seemingly inexplicable rage, and in the least resilient, despair. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - May 21, 2021 Category: Infectious Diseases Source Type: news
Animals are our overlooked allies in the fight against Covid | Melanie Challenger
It ’s important to recognise the vital role they’ve played in development of vaccines and treatmentsA few weeks ago, I received my first shot of a vaccine against Covid-19. As the newly vaccinated exited the clinic, there was a mix of relief and elation on people ’s faces. We exchanged little smiles of solidarity. If we could have burst into spontaneous applause, I’m sure we would have done.Recently, the lead scientist for the Oxford/AstraZeneca vaccine, Prof Sarah Gilbert,was honoured with the RSA Albert Medal. There are rumours that Gilbert ’s team, along with the pioneers of the mRNA vaccines, are up for a Nob...
Source: Guardian Unlimited Science - May 17, 2021 Category: Science Authors: Melanie Challenger Tags: Medical research Vaccines and immunisation Coronavirus Animals Science World news Source Type: news
South Africa: SA At Cutting Edge of TB Vaccine Research
[spotlight] It is a hundred years since the BCG (Bacille Calmette-Guerin) vaccine, the only registered vaccine proven to offer some protection against tuberculosis , was first used in people. A relative shortage of public funding and little interest from pharmaceutical companies to develop new unprofitable TB vaccines has frustrated scientific research in this area for most of the last century. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 26, 2021 Category: African Health Source Type: news
TB vaccine may protect newborns against other infectious diseases
(London School of Hygiene& Tropical Medicine) The tuberculosis (TB) vaccine Bacillus Calmette-Guerin (BCG) could protect newborns against a variety of common infections, such as upper respiratory tract infections, chest infections and diarrhoea, according to a new study in Lancet Infectious Diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 17, 2021 Category: Infectious Diseases Source Type: news
Tuberculosis Kills As Many People Each Year As COVID-19. It ’ s Time We Found a Better Vaccine
This article is republished from The Conversation under a Creative Commons license. Read the original article.
The post Tuberculosis Kills As Many People Each Year As COVID-19. It’s Time We Found a Better Vaccine appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - January 15, 2021 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health TerraViva United Nations tuberculosis Source Type: news
If Covid-19 is Primarily a ‘First World’ Virus, Why is the Global South in Lockdown?
A lockdown closer home. Secretary-General Antonio Guterres walking the empty corridors of the UN Secretariat building in New York in 2020. Credit: United NationsBy Darini Rajasingham-SenanayakeCOLOMBO, Sri Lanka, Jan 7 2021 (IPS) The currently available Covid-19 vaccines have been authorized for ‘emergency use ‘in Europe and North America. This is due to an apparent spike in Covid-19 flu cases in the northern hemisphere as winter advances. Highly advertised vaccines are being produced and rolled out at ‘warped speed’ by powerful pharmaceutical and bio-technology companies headquartered in Euro-America although thei...
Source: IPS Inter Press Service - Health - January 7, 2021 Category: International Medicine & Public Health Authors: Darini Rajasingham-Senanayake Tags: Aid Development & Aid Editors' Choice Featured Global Headlines Health Human Rights IPS UN: Inside the Glasshouse Population Poverty & SDGs TerraViva United Nations Source Type: news
Persistent pollutants linked to poor vaccine response
New research indicates that exposure to pollutants such as DDT and PCBs may dampen infants’ immune response to the tuberculosis vaccine. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - January 6, 2021 Category: Environmental Health Source Type: news
Why Africa ’s COVID-19 Outbreak Hasn’t Been as Bad as Everyone Feared
When COVID-19 initially blazed through Asia, Europe and then the United States, global public health experts worried that it could be catastrophic for Africa, with its crowded cities, poorly funded health sector and lack of testing facilities. The U.N. Economic Commission for Africa in April predicted up to 300,000 deaths this year if the virus couldn’t be contained on the continent. Yet it was the U.S, with its superior health system, that hit that grim milestone first, and so far, Africa has been largely spared the worst of the devastation experienced by the rest of the world. As of Dec. 29, the Africa Centres for ...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized COVID-19 Londontime Source Type: news
Vaccination against tuberculosis can reduce the spread of COVID-19 and ease its course
(St. Petersburg State University) St Petersburg University scientists have analysed about 100 academic papers and statistics on the incidence of COVID-19 in different countries of the world. Analysis of these data showed that the spread of the new coronavirus infection occurs more slowly where there is a large percentage of people vaccinated against tuberculosis with the BCG vaccine. Moreover, this vaccination itself, given in early childhood, changes the immune system in such a way that the new coronavirus disease course tends to be less severe. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 3, 2020 Category: Infectious Diseases Source Type: news
Battles Won – and Lost – Against AIDS Hold Valuable Lessons for Managing COVID-19
This article is republished from The Conversation under a Creative Commons license. Read the original article.
The post Battles Won – and Lost – Against AIDS Hold Valuable Lessons for Managing COVID-19 appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - November 30, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health World AIDS Day Source Type: news
Could the TB Vaccine Help Prevent COVID-19?
WEDNESDAY, Nov. 25, 2020 -- A widely used tuberculosis vaccine may help protect people against the new coronavirus or reduce the severity of COVID-19, a new study suggests.
The Bacillus Calmette-Gu érin (BCG) was developed in the early 1900s and is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 25, 2020 Category: General Medicine Source Type: news
BCG Vaccination Linked to Lower SARS - CoV - 2 Seroprevalence
Seroprevalence of anti - SARS - CoV - 2 IgG lower for health care workers with history of BCG vaccination (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 24, 2020 Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pathology, Pediatrics, Pulmonology, Journal, Source Type: news
BCG Vaccination Linked to Lower SARS-CoV-2 Seroprevalence
TUESDAY, Nov. 24, 2020 -- History of Bacillus Calmette-Guérin (BCG) vaccination is associated with decreased seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) among health care workers... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 24, 2020 Category: Pharmaceuticals Source Type: news
Study: TB vaccine linked to lower risk of contracting COVID-19
(Cedars-Sinai Medical Center) A widely used tuberculosis vaccine is associated with reduced likelihood of contracting COVID-19 (coronavirus), according to a new study by Cedars-Sinai. The findings raise the possibility that a vaccine already approved by the U.S. Food and Drug Administration may help prevent coronavirus infections or reduce severity of the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 20, 2020 Category: Infectious Diseases Source Type: news
Infographic: How Vaccines Train Innate Immunity
A recent study eludidates some of the changes that occur in the body after inoculation with a tuberculosis vaccine. (Source: The Scientist)
Source: The Scientist - November 1, 2020 Category: Science Tags: Infographics Magazine Issue Source Type: news
